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Abstract
Background: Numerous epidemiological studies have demonstrated adverse health effects of a sedentary life style,
on the one hand, and of acute and chronic exposure to traffic-related air pollution, on the other. Because physical
exercise augments the amount of inhaled pollutants, it is not clear whether cycling to work in a polluted urban
environment should be encouraged or not. To address this conundrum we investigated if a bicycle journey along
a busy commuting road would induce changes in biomarkers of pulmonary and systematic inflammation in a
group of healthy subjects.
Methods: 38 volunteers (mean age: 43 ± 8.6 years, 26% women) cycled for about 20 minutes in real traffic near a
major bypass road (road test; mean UFP exposure: 28,867 particles per cm
3) in Antwerp and in a laboratory with
filtered air (clean room; mean UFP exposure: 496 particles per cm
3). The exercise intensity (heart rate) and duration
of cycling were similar for each volunteer in both experiments. Exhaled nitric oxide (NO), plasma interleukin-6 (IL-6),
platelet function, Clara cell protein in serum and blood cell counts were measured before and 30 minutes after
exercise.
Results: Percentage of blood neutrophils increased significantly more (p = 0.004) after exercise in the road test
(3.9%; 95% CI: 1.5 to 6.2%; p = 0.003) than after exercise in the clean room (0.2%; 95% CI: -1.8 to 2.2%, p = 0.83).
The pre/post-cycling changes in exhaled NO, plasma IL-6, platelet function, serum levels of Clara cell protein and
number of total blood leukocytes did not differ significantly between the two scenarios.
Conclusions: Traffic-related exposure to particles during exercise caused a small increase in the distribution of
inflammatory blood cells in healthy subjects. The health significance of this isolated change is unclear.
Background
Abundant evidence from epidemiological and experi-
mental studies shows that traffic-related air pollution
has adverse effects on the respiratory and cardiovascular
systems[1-3]. A study in Europe attributed about half of
all mortality from air pollution to traffic sources [4]. It
is well-established that even daily average exposures to
particulate matter can cause acute health effects [5,6].
Different studies of humans exposed experimentally in
exposure chambers showed acute increases in both lung
and systemic inflammation [7-11].
Studies investigating real-life exposure of participation
in traffic also found significant associations with adverse
health effects. Peters et al. [12] showed that “participa-
tion in traffic” was associated with the risk of developing
myocardial infarction in the hour afterwards. McCrea-
nor et al. [13] investigated exposure to traffic-related air
pollution in a group of asthmatic subjects and found a
greater reduction in lung function, when subjects walked
for two hours along a busy street compared to walking
in a park. On the other hand, Strak et al. [14] found
only weak evidence for an association between exposure * Correspondence: tim.nawrot@uhasselt.be
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lung function and airway inflammation.
Commuters often find themselves in locations and
situations where they are in close vicinity to busy traffic.
They are thus acutely exposed to traffic exhaust, includ-
ing ultrafine particles (UFP) from diesel engines. Expo-
sure during commuting may therefore represent an
important fraction of the daily exposure to air pollution.
This is especially true for cyclists. Their higher minute
ventilation leads them to inhale higher amounts of pollu-
tants compared with sitting in a car [15,16]. On the other
hand, commuter cycling is a convenient way to include
moderate physical activity into the daily schedule [17].
Cycling to work is, therefore, promoted in the prevention
of obesity and to offset the health impact of a sedentary
life style. Moreover, cyclists do not pollute the air.
In other words, there is a contradiction between the
messages pointing to the beneficial effects of exercising
by cycling to work and those highlighting the adverse
health effects of traffic-related air pollution [18]. To
(partially) address this conundrum, we undertook a
“real-life” exposure study in healthy volunteers. In a
controlled experiment, non-asthmatic subjects cycled 20
minutes during two exposure scenarios: near a major
bypass road with busy traffic (road test) and in a room
with filtered air (clean room), and we assessed acute
effects on lung and systemic inflammation.
Methods
Study population
All subjects taking part in the ‘SHAPES injury surveil-
lance system’ [15] who had filled out at least two elec-
tronic diaries (n = 1048), received an e-mail asking if
they were willing to participate in the field tests. Briefly,
these participants had been previously asked to fill out
questionnaires about bicycle-related traffic accidents and
also to fill out a self-reported electronic diary for one
year with details about travel frequency, time spent
cycling and distance travelled. The inclusion criteria
were: (1) age between 18-65 years; (2) having a paid job
outside the home; (3) cycling to work at least twice a
week; (4) living in Belgium. Two hundred eighty-one
subjects were willing to participate. Of these 281
responders, after excluding smokers and those on anti-
platelet therapy, 41 were chosen in chronological order
and contacted personally by phone. Of the 41 recruited
subjects, 38 took part in the experiments at both loca-
tions. The Ethics Review Board of the Medical Faculty
of the Vrije Universiteit Brussel (VUB) approved the
study. All subjects gave a written informed consent.
Study design
Subjects performed two exercise trials during two expo-
sure scenarios: cycling on a cycling track near a major
bypass road in Antwerp (road test) and cycling in a
room with filtered air (clean room), 12 to 29 days apart.
The road tests were carried out over a five day period
(from 4 May 2009 until 8 May 2009) with a mean of
eight participants per day. T h et e s t si nt h ec l e a nr o o m
were done on 11 days (between 18 May 2009 and 3
June 2009), with a mean of three participants per day.
Test were carried out from 8 am until 17 pm. Persons
were asked to come by train and had to walk 1200
meters from the train station to the location in Antwerp
(road test) and 700meters to the location in Brussels
(clean room test).
We measured the anthropometric characteristics of
the participants and administered a questionnaire to col-
lect information about their lifestyle and medication
intake. A venous blood sample was drawn and exhaled
NO was measured, before the exercise. After the exer-
cise, participants rested for 30 minutes in a seated posi-
tion followed by the post-cycling examination, which
included exhaled NO measurement and a venous blood
sample collection.
Cycling near a major bypass road (road test)
Participants cycled a pre-selected route in Antwerp on a
dedicated cycling path parallel to a major bypass road (a
very busy 10 lane motorway with up to 200,000 vehicles
per day and a major flow of heavy duty diesel vehicles).
The total trajectory is 5750 meters long and mostly situ-
ated between 10 and 100 meters from the edge of the
motorway. The cycling path also passes over the motor-
way on a dedicated bridge. Participants were asked to
cycle at about the same intensity and speed as their
everyday cycling to and from work. They carried a heart
rate monitor (Polar X-Trainer Plus, Polar Electro OY,
Kempele, Finland) and the bicycle was equipped with
devices to measure exposure to particles (GRIMM and
P-TRAK) and a GPS.
Cycling in a room with filtered air (clean room)
To create a ‘clean room’, three devices were used simul-
taneously and continuously (i.e. 24 hours a day) during
the whole testing period, in a laboratory located, in
Brussels, at the VUB. The Bionaire® Mini Tower air
purifier (The Holmes Group, Inc., Milford, USA) was
used to purify the air from particles down to one μmb y
HEPA filters. Fine particles were excluded from the
ambient air with the MedicCleanAir® (Häri-Prolectron
AG, Bronschhofen, Switserland) and the Genano® 310
(Genano OY, Espoo, Finland). The MedicCleanAir
device also removes indoor gases, including ozone, from
ambient air. During the cycling test, on a cycloerg-
ometer in the laboratory, a steady state heart rate equal
to the individual’s mean heart rate measured during the
road test, was obtained. The exercise began with an
initial workload of 80 W for men and 50 W for women
at a pedalling rate of 70-80 rates per minute. The load
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heart rate during the first minute of exercise. The dura-
tion of the test was defined by the duration of the road
test.
Fine and ultrafine particles, present in the direct sur-
rounding of the participant, were constantly measured,
using the same GRIMM and P-TRAK devices as used
during the road test (see below).
Exposure measurements
To measure personal exposure to particulate matter
(PM10,P M 2.5 and UFP) during the road test and during
the clean room test, small portable, battery-powered,
devices were used. The GRIMM 1.108 Dust monitor
(Grimm Technologies Inc, USA) is a portable environ-
ment dust monitor that can simultaneously measure
PM1.0,P M 2.5,P M 10 and total suspended particulate
(TSP). Ultrafine particle counts at one-second resolution
were measured using P-TRAK Ultrafine Particle Coun-
ters (TSI Model 8525, USA) for particles in the size
range 0.02-1 μm( m a x i m u m5 0 0 , 0 0 0p a r t i c l e sp e rc m
3).
The P-TRAK is a hand-held, field instrument based on
the condensation particle counting technique using iso-
propyl alcohol. We refer to Berghmans et al. [19] and
Int Panis et al. [15] for a detailed description of the PM
and UFP measuring techniques while cycling in traffic.
To compare ambient PM2.5 PM10,N O ,N O 2 and ozone
concentrations between the two exposure scenarios (road
test and clean room), we compared these concentrations
obtained from fixed measuring stations, close to the loca-
tion of the road test and the clean room test.
Clinical endpoints
Exhaled NO
Fractional exhaled NO was measured with an electro-
chemistry-based NIOX MINO device (Aerocrine, Swe-
den). This instruments complies with ATS/ERS
recommendations [20]. The device contains a scrubber
which makes the inhaled air NO-free. The procedure
consists of maximal inhalation. Subjects were instructed
to monitor a flow rate as visualized on a display to
maintain a flow rate of 50 ml/second.
Blood collection and analysis
A non-fasting blood sample was collected in an EDTA
tube (4 mL), in a tube containing 0.129 M (3.8%)
sodium citrate (4.5 mL) and in a dry tube (5 mL). Blood
cell counts and differential leukocyte counts were deter-
mined using an automated cell counter with flow differ-
ential (Cell Dyn 3500, Abbott, USA). IL-6 was measured
on plasma samples with a commercially available ELISA
(Human IL-6 Quantikine, R&D Systems, UK). Clara cell
protein was measured on serum samples with an in
house latex immunoassay, using the rabbit anti-protein
1 antibody from Dakopatts (Glostrup, Denmark) [21].
Platelet function
Platelet function was assessed (within one hour of sam-
pling) with the Platelet Function Analyzer PFA-100 (Sie-
mens Healthcare Diagnostics, USA) [22]. The PFA-100
test cartridge consists of a capillary, a blood sample
reservoir and a membrane coated with collagen/epi-
nephrine with a central aperture. Whole blood is aspi-
rated through the capillary and the aperture, thus
exposing platelets to high shear rates (5000/s) and to
collagen and epinephrine, causing platelet activation. A
platelet thrombus forms at the aperture, thus gradually
diminishing and finally arresting blood flow. The time
from the start of aspiration until the aperture completely
occludes, i.e. the closure time, reflects platelet aggrega-
tion in a shear stress-dependent way.
Statistical analysis
For database management and statistical analysis, we
used SAS software (version 9.1; SAS Institute Inc., Cary,
NC, USA). Non-normally distributed values were log-
transformed. We used linear mixed-effects models with
adjustment for temperature, relative humidity and heart
rate to investigate pre-cycling vs. post-cycling measure-
ment on the studied parameters. Because within-indivi-
dual repeated measures of outcomes are correlated,
random effects were estimated at the subject level. To
study whether the change between pre/post-cycling
measurements was different per exposure scenario, we
included an interaction term between pre/post-cycling
measurement and the exposure scenario (road test vs.
clean room) in the model. We also ran the model with
an interaction term between pre/post-cycling measure-
ment and the UFP (or PM2.5)c o n c e n t r a t i o n sd u r i n g
cycling.
Results
Study population
Thirty-eight physically fit, non-asthmatic participants
(26% women) with a mean age of 43 years (range: 28-58
years) and mean body-mass index (BMI) of 24 kg/m
2,
participated (Table 1). Five persons reported hay fever.
Exposure measurements
The mean ambient air pollution (PM10), measured by the
automatic monitoring network, was the same on the days
of the road test compared with the PM10 concentration on
days of the clean room test (24.4 vs. 23.3 μg/m
3, p = 0.77).
This was also the case for ambient PM2.5 concentrations
(13.4 vs. 13.1 μg/m
3, p = 0.68) and NO2 concentrations
(30.2 vs 28.6, p = 0.15). However, NO concentrations were
higher on days of the road test as compared with the NO
concentrations on days that the clean room test was car-
ried out (7.2 vs 5.4 μg/m
3, p = 0.006) and ambient ozone
level were lower (48.3 vs 63.7 μg/m
3, p < 0.0001).
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participants were exposed, during the road test and in
the clean room are given in table 2. By design, concen-
trations of particles were higher during the road test
(Figure 1). Average temperature was higher and relative
humidity was lower in the clean room. By design the
duration of cycling and the heart rate did not differ
between the two exposure scenarios (road test and clean
room) (Table 2).
Clinical endpoints
Baseline values (before cycling) of the clinical para-
meters were not significantly different between the road
test and the clean room (Table 3). When we compared
the clinical parameters pre/post-cycling (Table 4), sepa-
rately for the two exposure scenarios (road test and
clean room), we observed a decrease in exhaled NO of
-4.4% change from baseline (p = 0.04) after the road
test, but not in the clean room (-1.3% change from base-
line; p = 0.63). However, the interaction term between
pre/post-cycling measurement of exhaled NO and the
exposure scenario was not significant (p = 0.38).
Platelet function, IL-6, Clara cell protein and total leu-
kocyte counts did not change significantly from baseline
after cycling, neither during the road test, nor in the
clean room. However, the percentage of blood neutro-
phils (though not their absolute number) increased by
3.9% after cycling in the road test (p = 0.003), but not
in the clean room (0.22%; p = 0.83). A significant inter-
action (p = 0.004) between percentage of neutrophils
and exposure scenario was observed.
In a model that included either UFP counts or PM2.5
concentrations, the interaction terms were only signifi-
cant for the percentage blood neutrophils and not for
the other measured parameters (Table 4).
Similar results were obtained if we excluded the five
persons that reported hay fever from our analysis.
Discussion
In subjects free of lung and cardiovascular disease, a
small, immediate (30 minutes after moderate exercise)
increase in the percentage of blood neutrophils was
observed in response to cycling in traffic-related expo-
sure. Platelet function and a biomarker of lung perme-
ability (Clara cell protein) did not show rapid changes
between pre/post-cycling measurements in either expo-
sure scenario. The change in pre/post-cycling measure-
ment of exhaled NO did not differ significantly between
the two scenarios.
NO is expressed by different cell types in the respira-
tory tract including epithelial cells, macrophages, neu-
trophils, mast cells and vascular endothelial cells [23].
Previous studies found that exhaled NO can be posi-
tively associated with exposure to air pollution both in
healthy adults [24-26] and asthmatic subjects [27].
Proinflammatory cytokines can induce iNOS (inducible
nitric oxide synthase), which releases large quantities of
NO several hours after exposure [23]. In our study,
exhaled NO was measured already 30 minutes after
exposure and we observed a decrease after cycling in
polluted air . It is known that smokers have lower levels
of exhaled NO, compared with non-smokers [28-30].
Exposure to environmental tobacco smoke is also asso-
ciated with decreases in exhaled NO [28,31-33]. The
mechanisms for this decrease are unclear. Accelerated
uptake of NO, inactivation of NO by oxidants, increased
breakdown of NO or damage to NO producing epithe-
lial cells by toxins may play a role in the observed
decrease of exhaled NO caused by active or passive
smoking [32].
Besides effects in the lung, we also looked at systemic
inflammation by measuring total and differential blood
leukocyte counts and plasma IL-6. We observed a signif-
icant increase in the percentage of blood neutrophils
after cycling in polluted air, but not in filtered air. No
changes occurred in plasma levels of IL-6. Neutrophils
Table 1 Characteristics (n = 38)
Mean (SD) or number (%)
Anthropometrics
Men/women 28/10 (74%/26%)
Age, years 43 (8.6)
BMI, kg/m
2 23.7 (3.1)
Lifestyle
Former smoker 16 (42%)
Exposure to environmental tobacco smoke 3 (8%)
Regular alcohol use 20 (53%)
Medication use
Antiplatelet medication 0 (0%)
Lipid-lowering medication 1 (3%)
Antihypertensive medication 3 (8%)
Table 2 Exposure measurements during the road test
and in the clean room
Endpoint Road test Clean room p-value*
Average PM10, μg/m
3 62.8 (23.6) 7.6 (3.3) <0.001
Average PM2.5, μg/m
3 24.2 (8.7) 2.0 (0.78) <0.001
Average UFP, particles/cm
3 28,867 (8479) 496 (138) <0.001
Duration of cycling, min 20.8 (1.6) 20.2 (1.9) 0.20
Temperature,°C 15.2 (1.6) 21.6 (1.0) <0.001
Relative humidity,% 57.0 (9.5) 45.7 (6.6) <0.001
Heart rate, beats/min 131 (15.0) 131 (14.6) 0.90
% of maximal heart rate 74.0% (8.6) 74.1% (8.8) 0.90
Values are Mean (SD).
*Paired t-test.
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has been shown that neutrophils are increased after
exposure to diesel exhaust [34].
We did not observe a significant increase in serum
Clara cell protein levels after cycling in polluted air. An
experimental animal study, with exposure to diesel
exhaust, enriched with concentrated PM2.5 did not
result in elevated serum Clara cell levels in the blood of
rats [35]. Increased serum Clara cell levels have been
associated with recent changes in PM2.5 in elderly [36]
and have also been reported in cyclists after 2 h of
cycling during an ozone episode [37].
T h e r ew a sas u b s t a n t i a ld i f f e r e n c ei ne x p o s u r et o
ultrafine particles between cycling during the road test
and cycling in the clean room. However when we com-
pare our values of ultrafine particles counts (28,867 per
cm
3) with those of other studies, we must conclude that
exposure in our study was not very high. In Oxford
Street, concentrations of PM2.5 were similar (median: 28
μg/m
3; range 14 to 76 μg/m
3) while concentrations of
PM10 (median 125 μg/m
3; range 62 to 161 μg/m
3)a n d
ultrafine particle counts (median 64,000 per cm
3;r a n g e
40,000 to 92,000 per cm
3) were about twice as high
than in our experiment. On the other hand, in that
study [13], even in Hyde Park, exposure was higher than
in our study which used filtered air as a control situa-
tion. Strak et al. [14] found a median exposure in the
high polluted traffic route of 41,097 particles/cm
3.I n
addition, the mean duration of cycling was 20 minutes
in our experiment, which is a realistic time, comparable
with commuting from home to work. Similar experi-
ments [13,14] have used exposure times of up to two
hours, which is six times longer than in our study. Com-
bined with the lower exposure concentrations, this
means that the total exposure to UFP in our experiment
was about an order of magnitude lower than in the few
similar studies of the literature [13,14]. Moreover, our
study included only healthy, trained cyclists. It is, there-
fore, remarkable that even at these low exposures, we
were able to detect significant changes, although it
might explain the fact that we only see minor changes
in the measured health parameters.
The exercise during the road test and the clean room
test was tightly controlled, thus minimizing bias. In the
clean room the heart rate and the duration of cycling
was the same as during the field test. These conditions,
together with the fact that subjects had no other expo-
sure after cycling and before the second blood sampling,
strengthen the causality of the preclinical changes in
association with traffic-related exposure in healthy
volunteers. On the other hand, it is not clear whether
these observations imply long-term negative health out-
comes in regular commuter cyclists. Strong evidence
exists that regular physical activity contributes to the
prevention of chronic conditions and that it is asso-
ciated with a reduced risk of premature death [38-40].
This study has limitations. The number of participants
was rather small. Test persons were healthy, experienced
cyclists, because we wanted to test real-life exposure in
commuters. But therefore, observed effect could be
underestimated. Health effects were measured very
Table 3 Comparison of baseline values between the road
test and the clean room
Endpoint Road test Clean room
Exhaled NO, ppb 29 (19 - 41) 24 (15 - 39)
PFA closure time, s 163 (135-197) 154 (125-176)
Plasma IL-6, pg/mL 1.47 (0.99-2.28) 1.53 (1.20-1.90)
Clara cell protein, μg/L 7.7 (5.6-11.5) 7.7 (5.6-10.3)
Blood leukocyte counts, per μL 4964 (1208) 4883 (1174)
Blood neutrophil counts, per μL 2937 (874) 2888 (884)
Percentage blood neutrophils,% 59 (8.0) 59 (7.1)
Data are geometric mean (25-75 percentile) for non-normally distributed
variables or mean (SD) for normally distributed variables.
Paired t-test: p > 0.08.
Table 4 Percent change (pre/post-cycling) in endpoints per exposure scenario (road test or clean room)
Endpoint Road test Clean room p-value for interaction
Percent change (95%CI) p-value Percent change (95%CI) p-value Exposure scenario* UFP
† PM2.5
‡
Exhaled NO, -4.4% (-8.3% to -0.37%) 0.04 -1.3% (-6.5% to 4.1%) 0.63 0.38 0.63 0.50
PFA closure time 6.5% (-1.0% to 14.5%) 0.10 5.1% (-1.0% to 11.6%) 0.11 0.76 0.60 0.59
Plasma IL-6 17.4% (-6.7% to 47.9%) 0.18 -2.9% (-19.0% to 16.4%) 0.75 0.21 0.38 0.40
Clara cell protein 1.6% (-10.8% to 15.8%) 0.82 -0.27% (-11.7% to 12.7%) 0.97 0.90 0.91 0.80
Blood leukocyte counts 1.3% (-2.0% to 4.6%) 0.44 2.5% (-1.1% to 6.0%) 0.19 0.75 0.97 0.71
Blood neutrophil counts 4.6% (0.48% to 8.7%) 0.04 2.4% (-2.3% to 7.2%) 0.32 0.36 0.35 0.20
Percentage blood neutrophils 3.9% (1.5% to 6.2%) 0.003 0.22% (-1.8% to 2.2%) 0.83 0.004 0.02 0.01
Analysis adjusted for temperature, relative humidity and heart rate.
*p-value for the interaction between pre/post-cycling measurements and exposure scenario (road test or clean room).
†p-value for the interaction between pre/post-cycling measurements and UFP concentrations.
‡p-value for the interaction between pre/post-cycling measurements and PM2.5 concentrations.
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effects that appear later, could have been missed. On
the other hand, the short time-frame between exposure
and post-measurement minimizes other exposure after
cycling. Pollen or aeroallergen levels were not taken into
consideration. Finally, the conditions during the road
test and in the clean room are not entirely comparable.
Although we tried to minimize bias between the road
test and the clean room test, by tightly controlling exer-
cise (e.g heart rate and duration of cycling), we did not
take into account noise and stress levels persons were
exposed to during the road test.
It is not unusual for health promotion messages to
face contradictions or ambiguities when promoting one
measure to benefit health (e.g. daily cycling) while
potentially increasing the risk of an adverse effect (e.g.
increasing exposure to air pollution). This may pose
problems of scientific credibility and/or acceptance of
the health education messages. For instance, smokers
are sometimes reluctant to stop smoking because they
will gain weight, which is also a risk factor for prema-
ture death. Similarly, promoting breast feeding to pro-
tect infants against infections and perhaps future allergy,
also leads to a high exposure of the infant to lipid-solu-
ble pollutants (e.g. persistent organic pollutants, such as
DDT, PCBs, dioxins) [41,42]. Promoting the regular
consumption of fish to increase the intake of polyunsa-
turated fats may also lead to exceed the intake of PCBs
[43]. In general, the consensus is that the beneficial
effects of smoking cessation, breast feeding, or a
balanced diet outweigh the hypothetical negative side
effects, at the individual level. However, this does not
mean that public health efforts should not be directed
at minimizing the adverse effects.
Conclusion
In conclusion, we observed in healthy cyclists, a small,
immediate (30 minutes after moderate exercise) increase
in the percentage of blood neutrophils. We do not
believe, based on our limited findings, that healthy peo-
ple should be discouraged from cycling to work in
heavy traffic (provided it is safe), although from a public
health point, cycling tracks should be developed away
from busy roads. More importantly, traffic-related pollu-
tion should be decreased.
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